Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-25-005446
Filing Date
2025-04-24
Accepted
2025-04-24 17:11:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ntra-20250424xdefa14a.htm DEFA14A 11768
2 GRAPHIC ntra-20250424xdefa14a_bg001.jpg GRAPHIC 153034
3 GRAPHIC ntra-20250424xdefa14a_bg002.jpg GRAPHIC 110457
  Complete submission text file 0001558370-25-005446.txt   376064
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37478 | Film No.: 25868860
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)